Stem Cells & the future of regenerative medicine – with Dr. Mathias Bernow, CEO of Cellcolabs
One Thirty BiohacksShow Notes
In this episode of One Thirty Biohacks, we explore the fascinating and fast-evolving world of stem cells and regenerative medicine with Mathias Bernow, CEO and co-founder of Cellcolabs
Stem cell therapies are gaining momentum within both clinical and lifestyle medicine—but what is science-based and what is still emerging? In this episode, Mathias breaks down what stem cells actually are, how they work, and where the real therapeutic potential lies—from orthopaedics and chronic inflammation to immune health, injury recovery and longevity.
We discuss the challenges of building a responsible company in a rapidly growing, often misunderstood field, and why regulation, sourcing and safety are crucial to move this space forward in a meaningful way.
Whether you’re simply curious or already exploring regenerative treatments as part of your health journey, this episode offers a grounded and accessible introduction to one of the most promising areas of future medicine.
If you’re interested in learning more or exploring whether stem cell therapy could be relevant for you, don’t hesitate to reach out — we’re happy to help connect you to the right experts.
LinkedIn: Mathias Bernow Hosted on Acast. See acast.com/privacy for more information.
More from One Thirty Biohacks
Red light therapy is everywhere. From LED masks to full-body panels, the technology is becoming increasingly popular. But how much do we really know about how it works, and how can we tell which devices are worth investing in?
What if the problem with Ozempic isn’t the peptide, it’s the dose?
Why does a supplement work brilliantly for one person and do almost nothing for another?
What if the future of longevity isn’t just about living longer, but changing how we age?
Could stem cells change the way we approach healing and regeneration? In this episode, Dr. Torbjörn Ogéus explores the science of stem cells, their role in tissue repair and the emerging research into pluripotent cells in adult blood.